Uterine mechanical properties, particularly tissue stiffness, are dynamically regulated during the embryo implantation window to ensure optimal mechanocompatibility. However, maternal aging and fibrotic pathologies, such as adenomyosis and …
This study mainly reports the efficacy of Nei Yi formula with diphereline in patients with ovarian endometriomas after surgery and its influence on ovarian functioning. 115 ovarian endometriomas individuals treated in our hospital were sele…
BACKGROUND: Endometrioid adenocarcinoma is usually diagnosed by endometrial curettage with a positive rate of 94%, while a hysteroscopic examination can increase the positive rate. Differently, endometrioid adenocarcinoma arising from adeno…
Objective To investigate the clinical characteristics of preadolescent and adolescent female patients with ovarian mass combined with dysplasia of secondary sexual characteristics. Methods This study retrospectively analyzed 18 cases of ova…
Well-differentiated papillary mesothelioma (WDPM) is an uncommon mesothelial tumor. The lesions may be single or multiple and usually behave in a benign or indolent fashion, sometimes persisting for many years. In the present case, a 37-yea…
OBJECTIVE: To investigate the molecular mechanism of PPARγ impacting the paroxysm of endometriosis. METHODS: Immunohistochemistry, qRT-PCR and Western Blot were used to determine the expression level of PPARγ and MAT2A in Eu, Ec and normal …
Endometriosis is closely associated with inflammatory reactions and angiogenesis. Whether PPARγ is a target for the treatment of endometriosis remains unknown. The present study was designed to investigate the impact of a PPARγ agonist (ros…
The invention relates to a compound oral preparation containing gossypol acetate and other drugs. The compound oral preparation mainly contains gossypol acetate, potassium chloride, vitamin B1 and vitamin B6 and is available in the form of …
The invention relates to a compound oral preparation containing gossypol acetate and other drugs. The compound oral preparation mainly contains gossypol acetate, potassium chloride, vitamin B1 and vitamin B6 and is available in the form of …
The invention relates to a compound oral preparation containing gossypol acetate and other drugs. The compound oral preparation mainly contains gossypol acetate, potassium chloride, vitamin B1 and vitamin B6 and is available in the form of …
The invention relates to a compound oral preparation containing gossypol acetate and other drugs. The compound oral preparation mainly contains gossypol acetate, potassium chloride, vitamin B1 and vitamin B6 and is available in the form of …
The invention relates to a compound oral preparation containing gossypol acetate and other drugs. The compound oral preparation mainly contains gossypol acetate, potassium chloride, vitamin B1 and vitamin B6 and is available in the form of …
The invention relates to a compound oral preparation containing gossypol acetate and other drugs. The compound oral preparation mainly contains gossypol acetate, potassium chloride, vitamin B1 and vitamin B6 and is available in the form of …
The invention relates to a compound oral preparation containing gossypol acetate and other drugs. The compound oral preparation mainly contains gossypol acetate, potassium chloride, vitamin B1 and vitamin B6 and is available in the form of …
The invention relates to a compound oral preparation containing gossypol acetate and other drugs. The compound oral preparation mainly contains gossypol acetate, potassium chloride, vitamin B1 and vitamin B6 and is available in the form of …
The invention relates to a compound oral preparation containing gossypol acetate and other drugs. The compound oral preparation mainly contains gossypol acetate, potassium chloride, vitamin B1 and vitamin B6 and is available in the form of …
The invention relates to a compound oral preparation containing gossypol acetate and other drugs. The compound oral preparation mainly contains gossypol acetate, potassium chloride, vitamin B1 and vitamin B6 and is available in the form of …
The invention relates to a compound oral preparation containing gossypol acetate and other drugs. The compound oral preparation mainly contains gossypol acetate, potassium chloride, vitamin B1 and vitamin B6 and is available in the form of …
The invention relates to a compound oral preparation containing gossypol acetate and other drugs. The compound oral preparation mainly contains gossypol acetate, potassium chloride, vitamin B1 and vitamin B6 and is available in the form of …
The invention relates to a compound oral preparation containing gossypol acetate and other drugs. The compound oral preparation mainly contains gossypol acetate, potassium chloride, vitamin B1 and vitamin B6 and is available in the form of …
The invention relates to a compound oral preparation containing gossypol acetate and other drugs. The compound oral preparation mainly contains gossypol acetate, potassium chloride, vitamin B1 and vitamin B6 and is available in the form of …
The invention relates to a compound oral preparation containing gossypol acetate and other drugs. The compound oral preparation mainly contains gossypol acetate, potassium chloride, vitamin B1 and vitamin B6 and is available in the form of …
The invention relates to a compound oral preparation containing gossypol acetate and other drugs. The compound oral preparation mainly contains gossypol acetate, potassium chloride, vitamin B1 and vitamin B6 and is available in the form of …
The invention relates to a compound oral preparation containing gossypol acetate and other drugs. The compound oral preparation mainly contains gossypol acetate, potassium chloride, vitamin B1 and vitamin B6 and is available in the form of …
The invention relates to a compound oral preparation containing gossypol acetate and other drugs. The compound oral preparation mainly contains gossypol acetate, potassium chloride, vitamin B1 and vitamin B6 and is available in the form of …